March 17, 2020 / 1:07 PM / 17 days ago

BRIEF-Celon Pharma Starts Strategic Programme To Seek Effective Medicines And Therapeutic Regimen For Covid-19

March 17 (Reuters) - Celon Pharma SA:

* ON CORONAVIRUS: INITIATES STRATEGIC PROGRAMME OF TESTING, VERIFICATION AND SEEKING EFFECTIVE MEDICINES AND/OR THERAPEUTIC REGIMEN FOR COVID-19

* ON CORONAVIRUS: ESTIMATES THAT CLINICAL TESTS FOR MOST EFFECTIVE MEDICINE COMBINATION CHOSEN COULD START WITH BEGINNING OF 2021

* CO WILL PARTICULARLY EVALUATE TWO KINASE INHIBITING DRUGS CURRENTLY UNDER DEVELOPMENT CPL409116 AND CPL302215

* ON CORONAVIRUS: MANAGEMENT BELIEVES COVID-19 AND OTHER POTENTIAL DISEASES RELATED TO CORONAVIRUS WILL BE LONG-TERM, SIGNIFICANT BUSINESS SECTOR

* CO TO EVALUATE KINASE INHIBITING DRUGS IN MONOTHERAPY AND IN COMBINATION WITH ANTIVIRAL DRUGS INCLUDING CO’S LAZIVIR DRUG Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below